Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan
Vanderbilt-Ingram Cancer Center · with National Cancer Institute (NCI) · NCT06482957
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Any age listed · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 2100
- US sites recruiting
- 1
- Study start
- April 1, 2022
- Record last updated
- September 19, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study evaluates the impact that a sarcoma diagnosis and treatment have had on patients over time.
Being studied: Surveys; Blood Collection; Saliva Collection; Urine Collection; Stool Collection; Tissue collection; Physical Activity Monitoring
Conditions: Sarcoma
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Patients at any age with a history of sarcoma, with or without evidence of a persistent disease
- For pediatric patients
- Parent/primary caregiver of patient
- Sibling of patient aged 8 years or older
Recruiting US locations
Vanderbilt University/Ingram Cancer Center
Nashville, TN 37203
Site contact: Vanderbilt-Ingram Service for Timely Access · 800-811-8480 · cip@vumc.org
Study contacts (from the official record)
- Vanderbilt-Ingram Services for Timely Access · 800-811-8480 · cip@vumc.org
Similar studies in Tennessee
All healthy volunteers studies in Tennessee →- RecruitingHealthy volunteersPhase 1/Phase 2
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Xencor, Inc.
- Location
- Cordova, TN + 27 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingHealthy volunteersPhase 1/Phase 2
Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.
Sanofi
- Location
- Knoxville, TN + 15 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1/Phase 2
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Novartis Pharmaceuticals
- Location
- Knoxville, TN + 18 other US sites
- Eligibility basics
- Ages 18–100
- RecruitingHealthy volunteersPhase 1
A First in Human Study of the Safety, Tolerability, and the Physiologically Based Pharmacokinetics of XFB19 in Healthy Adult Volunteers.
Xfibra, Inc.
- Location
- Knoxville, TN
- Eligibility basics
- Ages 18–55